These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 19433570)

  • 41. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
    Huang J; Tang YQ; Sun JY
    Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colistin pharmacokinetics: the fog is lifting.
    Couet W; Grégoire N; Marchand S; Mimoz O
    Clin Microbiol Infect; 2012 Jan; 18(1):30-9. PubMed ID: 21988234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.
    Jitmuang A; Nation RL; Koomanachai P; Chen G; Lee HJ; Wasuwattakul S; Sritippayawan S; Li J; Thamlikitkul V; Landersdorfer CB
    J Antimicrob Chemother; 2015; 70(6):1804-11. PubMed ID: 25698772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New Predictive Equation for the Estimation of Plasma Concentrations of Formed Colistin in Patients Treated With Colistimethate Sodium for Multidrug-Resistant Gram-Negative Bacterial Infections.
    Luque S; Sorlí L; Li J; Fernández-Sala X; Berenguer N; Colominas-González E; Benítez-Cano A; Montero MM; Subirana I; Prim N; García-Paricio R; Horcajada JP; Grau S
    Ther Drug Monit; 2024 Oct; 46(5):594-602. PubMed ID: 38984536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic evaluation of colistin sodium.
    Michalopoulos AS; Karatza DC; Gregorakos L
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):245-55. PubMed ID: 21128824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of colistin methanesulfonate (CMS) in healthy Chinese subjects after single and multiple intravenous doses.
    Zhao M; Wu XJ; Fan YX; Zhang YY; Guo BN; Yu JC; Cao GY; Chen YC; Wu JF; Shi YG; Li J; Zhang J
    Int J Antimicrob Agents; 2018 May; 51(5):714-720. PubMed ID: 29305956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
    Zaidi ST; Al Omran S; Al Aithan AS; Al Sultan M
    J Clin Pharm Ther; 2014 Jun; 39(3):272-6. PubMed ID: 24593154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.
    Falagas ME; Sideri G; Vouloumanou EK; Papadatos JH; Kafetzis DA
    Pediatr Infect Dis J; 2009 Feb; 28(2):123-7. PubMed ID: 19116601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colistin combination therapy improves microbiologic cure in critically ill patients with multi-drug resistant gram-negative pneumonia.
    Parchem NL; Bauer KA; Cook CH; Mangino JE; Jones CD; Porter K; Murphy CV
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1433-9. PubMed ID: 27230510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
    Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
    Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
    Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
    Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dosing guidance for intravenous colistin in critically-ill patients.
    Nation RL; Garonzik SM; Thamlikitkul V; Giamarellos-Bourboulis EJ; Forrest A; Paterson DL; Li J; Silveira FP
    Clin Infect Dis; 2017 Mar; 64(5):565-571. PubMed ID: 28011614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation of colistin utilization in the treatment of multidrug-resistant gram-negative nosocomial bloodstream ınfections in children and literature review.
    Genis C; Kaman A; Öztürk B; Tanır G
    Eur J Pediatr; 2024 Aug; 183(8):3407-3415. PubMed ID: 38767692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn].
    Zhang JP; Yang XS; Chen J; Peng YZ; Huang YS
    Zhonghua Shao Shang Za Zhi; 2009 Oct; 25(5):372-6. PubMed ID: 19951562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of colistin in adult patients: A cross-sectional study.
    Giacobbe DR; Saffioti C; Losito AR; Rinaldi M; Aurilio C; Bolla C; Boni S; Borgia G; Carannante N; Cassola G; Ceccarelli G; Corcione S; Dalla Gasperina D; De Rosa FG; Dentone C; Di Bella S; Di Lauria N; Feasi M; Fiore M; Fossati S; Franceschini E; Gori A; Granata G; Grignolo S; Grossi PA; Guadagnino G; Lagi F; Maraolo AE; Marinò V; Mazzitelli M; Mularoni A; Oliva A; Pace MC; Parisini A; Patti F; Petrosillo N; Pota V; Raffaelli F; Rossi M; Santoro A; Tascini C; Torti C; Trecarichi EM; Venditti M; Viale P; Signori A; Bassetti M; Del Bono V; Giannella M; Mikulska M; Tumbarello M; Viscoli C;
    J Glob Antimicrob Resist; 2020 Mar; 20():43-49. PubMed ID: 31207379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Whole-Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat.
    Bouchene S; Marchand S; Couet W; Friberg LE; Gobin P; Lamarche I; Grégoire N; Björkman S; Karlsson MO
    Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):407-422. PubMed ID: 29665289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colistin Use in Patients with Extreme Renal Function: From Dialysis to Augmented Clearance.
    Aitullina A; Krūmiņa A; Svirskis Š; Purviņa S
    Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30709064
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetics of colistin in patients with multidrug-resistant Gram-negative infections: A pilot study.
    Gautam V; Shafiq N; Mouton JW; Malhotra S; Kaur S; Ray P
    Indian J Med Res; 2018 Apr; 147(4):407-412. PubMed ID: 29998877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of colistin and colistimethate sodium after a single 80-mg intravenous dose of CMS in young healthy volunteers.
    Couet W; Grégoire N; Gobin P; Saulnier PJ; Frasca D; Marchand S; Mimoz O
    Clin Pharmacol Ther; 2011 Jun; 89(6):875-9. PubMed ID: 21544080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.